Graphical Abstract Highlights d Tissue-specific ILC2s are the primary source of OX40L after IL-33 stimulation d ILC2s from Il7r Cre Tnfsf4 fl/fl mice do not express OX40L upon IL-33 stimulation d OX40L expression by ILC2s is required for IL-33-driven Th2 and Treg cell expansion d Il7r Cre Tnfsf4 fl/fl mice have impaired Th2 and Treg cell responses
In Brief
Type 2 immunity underpins diverse processes central to tissue homeostasis, allergic inflammation, and anti-helminth immunity. Halim et al. demonstrate that the local expansion of Th2 and Treg cells in response to the alarmin IL-33 is dependent on the expression of the costimulatory molecule OX40L by type 2 innate lymphoid cells (ILC2s), revealing a central role for the IL-33-ILC2-OX40L pathway in the orchestration of type 2 immunity.
SUMMARY
The local regulation of type 2 immunity relies on dialog between the epithelium and the innate and adaptive immune cells. Here we found that alarmininduced expression of the co-stimulatory molecule OX40L on group 2 innate lymphoid cells (ILC2s) provided tissue-restricted T cell co-stimulation that was indispensable for Th2 and regulatory T (Treg) cell responses in the lung and adipose tissue. Interleukin (IL)-33 administration resulted in organ-specific surface expression of OX40L on ILC2s and the concomitant expansion of Th2 and Treg cells, which was abolished upon deletion of OX40L on ILC2s (Il7ra Cre/+ Tnfsf4 fl/fl mice). Moreover, Il7ra Cre/+ Tnfsf4 fl/fl mice failed to mount effective Th2 and Treg cell responses and corresponding adaptive type 2 pulmonary inflammation arising from Nippostrongylus brasiliensis infection or allergen exposure. Thus, the increased expression of OX40L in response to IL-33 acts as a licensing signal in the orchestration of tissue-specific adaptive type 2 immunity, without which this response fails to establish.
INTRODUCTION
Type 2 immunity underpins numerous key homeostatic and immune processes in health and disease (Pulendran and Artis, 2012) . The type 2 cytokine environment is regulated at the tissue level by the release of epithelium-derived type 2 cytokines, including interleukin (IL)-25, thymic stromal lymphopoietin (TSLP), and the alarmin IL-33. These molecules elicit the produc-tion of type 2 effector cytokines from immune cells, which are fundamental for diverse functions, ranging from anti-helminth parasite immunity to allergic inflammation, wound healing responses, and metabolism (Gause et al., 2013; Man et al., 2017) . Indeed, the tissue-and context-specific production of type 2 alarmins likely governs their downstream physiological functions. Adaptive type 2 immunity is driven by CD4 + T helper 2 (Th2) cells, which are the major source of type 2 inflammatory cytokines. However, CD4 + regulatory T (Treg) cells are increasingly associated with some type 2 inflammatory functions, such as wound healing and adipose tissue homeostasis (Odegaard and Chawla, 2015; Panduro et al., 2016) . The nature of the Treg cell association with type 2 immunity remains enigmatic and ranges from suppressive to synergistic. Indeed, Th2 and Treg cell subsets can respond directly to type 2 alarmins such as IL-33 and express overlapping transcriptional and functional programs (Siede et al., 2016; Wohlfert et al., 2011) . While adaptive type 2 immune cells are rare in most tissues under homeostatic conditions, innate group 2 innate lymphoid cells (ILC2s) are tissue-resident cells and rapidly respond to type 2 alarmins by producing factors shared with both Th2 (IL-5 and IL-13) and Treg (Amphiregulin) cell function. The division of labor, and interactions, between ILC2s and adaptive type 2 immune cells remains a fundamental and unresolved question.
Roles for ILC2s directly regulating CD4 + T helper cell activation have been proposed recently (Drake et al., 2014; Mirchandani et al., 2014; Oliphant et al., 2014; von Burg et al., 2014) . MHCII-expressing ILC2s interact with antigen-specific T cells to instigate a dialog in which ILC2 and T cell crosstalk contributes to their mutual maintenance, expansion, and cytokine production (Mirchandani et al., 2014; Oliphant et al., 2014) . ILC2s can also modulate T cell function, not by acting directly on naive CD4 + T cells but by collaborating with dendritic cells (DCs) to induce Th2 cell activation (Halim et al., , 2016 . Notably, (A-C) WT mice were treated with PBS or IL-33 (i.n., day 0 and 1) and analyzed on day 5 for Foxp3 and GATA3 expression in lung CD4 + T cells (A). Indicated populations (IL-33-treated shown) were subsequently analyzed for expression of Helios and neuropilin-1 (Nrp-1) (B) and CTLA4 (C). (D) RNA-seq was performed on lung Foxp3 egfp+ GATA3 hDC2+ and Foxp3 egfp+ GATA3 hDC2À Treg cells, Foxp3 egfpÀ GATA3 hDC2+ Th2 cells, and ILC2s on day 5 after treatment with PBS or IL-33 (i.n., day 0 and 1). Shown is a Venn diagram of transcripts expressed in each cell population (>10 RPKM). (E) Mice were treated with IL-33 and 2W1S-peptide as indicated (i.n., day 0 and 1), followed by quantification of 2W1S-Tetramer +/À Foxp3 + GATA3 + Treg cells and Foxp3 À GATA3 + Th2 cells in the lung on day 5.
(legend continued on next page) the importance of the local tissue environment is highlighted by the observation that the response to systemic antigen exposure is not sensitive to the absence of ILC2s . In contrast to these models where ILC2 help initiates and maintains type 2 responses, it has been proposed that ILC2 and CD4 + T cell responses develop independently and that it is the tissue-localized exposure of these cells to locally produced cytokines that acts as a checkpoint in the activation of a type 2 response, rather than the interaction of these cells within the tissue (Van Dyken et al., 2016) . Thus, the interplay between ILC2s and adaptive type 2 immune cells is likely to differ depending on anatomical location, activating signals, and temporal phase of the immune response.
In addition to the MHCII-mediated activation of helper T cells, the cognate interaction between the co-stimulatory molecule ICOSL on ILC2s and ICOS on T cells promotes Treg cell accumulation following IL-33 administration (Molofsky et al., 2015) . This is in addition to the ICOS-ICOSL autocrine signals that can enhance ILC2 proliferation (Maazi et al., 2015) . An in vitro study also suggested the potential contribution for OX40 ligand (OX40L) expressed on ILC2s for the co-stimulation of T cells, though its role in vivo was not explored (Drake et al., 2014) . Ligation of OX40 by OX40L, encoded respectively by the genes Tnfrsf4 and Tnfsf4, provides an important signal for the expansion or survival of Th2 cells, while less is understood about these effects on Treg cells (Croft, 2010; Webb et al., 2016) . OX40 is constitutively expressed at baseline on Treg cells and is induced on Th2 cells after T cell receptor (TCR)-mediated activation, while OX40L expression is reported on numerous immune cells but most notably on professional antigen-presenting cells such as DCs. Specifically, OX40L expression by DCs is important for effective Th2 cell responses to helminth-derived antigen . OX40 binding to OX40L activates TNF receptor associated factor (TRAF) signaling pathways that synergize with TCR or cytokine-derived stimulation (Croft, 2010; Webb et al., 2016) .
Here we found that ILC2s express high levels of OX40L after exposure to IL-33. No other immune cells that we analyzed in the lung, including lung DCs, expressed OX40L in vivo in response to exogenously administered type 2 alarmins, including TSLP. OX40L expression on ILC2s was tissue restricted and correlated with local expansion of adaptive type 2 immune cells. ILC2s and OX40 were critical for tissue-specific IL-33-driven Th2 and Treg (preferentially GATA3 + Treg) cell responses. ILC2-targeted deletion of OX40L (Il7r Cre/+ Tnfsf4 fl/fl ) significantly impaired Th2 and Treg cell expansion following allergen exposure and Nippostrongylus brasiliensis helminth infection, with profound effects on overall type 2 inflammation. Thus, OX40L expression on ILC2s in response to epithelial cell-derived alarmins is a critical checkpoint for orchestrating adaptive type 2 responses.
RESULTS
ILC2 Are Critical for Regulating Adaptive Type 2 Immunity Airway exposure to the protease allergen papain results in IL-33dependent accumulation of GATA3 + ILC2s and Th2 cells. The transcription factor GATA3 is critical for the development and function of type 2 cytokine-producing ILC2s and Th2 cells and is also expressed in a subset of Foxp3 + Treg cells associated with enhanced function and tissue residency (Hoyler et al., 2012; Mjö sberg et al., 2012; Wohlfert et al., 2011; Zheng and Flavell, 1997) . We found that lung GATA3 + Treg cells were also strongly and preferentially induced by papain and IL-33, compared to GATA3 À Treg cells (17.7-fold compared to 7.1fold increase, respectively) (Figures S1A-S1D). GATA3 + Treg cells in control (PBS), papain-, or IL-33-exposed lungs were likely thymus derived, as indicated by co-expression of the transcription factor Helios and the vascular endothelial growth factor (VEGF) co-receptor neuropillin (Nrp)-1 ( Figures 1A, 1B , and S1E; Thornton et al., 2010; Yadav et al., 2012) . GATA3 + Treg cells also expressed more CTLA4 compared to GATA3 À Treg cells in naive and IL-33-treated mice ( Figures 1C and S1F ). We purified Th2 cells, GATA3 + and GATA3 À Treg cells, and ILC2s from naive and IL-33-treated Foxp3 EGFP-DTR/+ Gata3 hCD2/+ mice and performed RNA-seq gene expression analysis (Figures 1D, S1G, and S1H, and Tables S1 and S2). Gene expression data were consistent with flow cytometry findings. Moreover, we observed substantial overlap between ILC2s, GATA3 + Treg cells, and Th2 cells during homeostasis and after in vivo IL-33 stimulation, supporting the idea of shared regulatory and functional programs between these cells (Panduro et al., 2016; Siede et al., 2016) .
IL-33 is known to have direct effects on Treg cells, which express its receptor ST2 ( Figure S1I ; Schiering et al., 2014) . However, we observed no significant proliferative advantage of ST2 + over ST2 À Treg cells after IL-33-induced expansion as assessed by Ki67 staining, or in an adoptive transfer experiment of mixed WT and Il1rl1 À/À CD4 + T cells, thus suggesting that an alternative mechanism contributes to IL-33-mediated Treg cell expansion (Figures S1J-S1M). Given that ILC2s can regulate Th2 cells in vivo via direct (Drake et al., 2014; Mirchandani et al., 2014; Oliphant et al., 2014) and indirect (Halim et al., , 2016 mechanisms and can regulate Treg cells via an ICOS-ICOSL interaction in vitro (Molofsky et al., 2015) , we tested whether IL-33-driven Treg cell expansion was ILC2 dependent in two models of ILC2 deficiency ( Figures S2A and S2F ). The 2W1S peptide immunogen, co-administered with IL-33, was used to track antigen-specific CD4 + T cell responses using the 2W1S:I-A b MHCII tetramer (Moon et al., 2007) . We found that both antigen-specific and non-specific (2W1S:tetramer + and À ) Treg and Th2 cell responses were impaired in ILC2-deficient Il7ra Cre/+ Rora fl/fl mice ( Figures 1E, S2B , and S2C). As a subset of CD4 + T cells can also express Rora, we generated (F) Mice were treated with IL-33 (i.n., day 0 and 1) followed by quantification of Foxp3 + GATA3 + and À Treg cells and Foxp3 À GATA3 + Th2 cells in the lung on day 5. (G) PBS-or diphtheria toxin (DTX)-treated ICOS-T mice were administered with IL-33 and 2W1S-peptide as indicated (i.n., day 0 and 1), followed by quantification of 2W1S-Tetramer +/À Foxp3 + GATA3 + Treg and Foxp3 À GATA3 + Th2 cells in the mLN on day 5. Cd4 Cre/+ Rora fl/fl mice, which showed no defect in type 2 immune-mediated expulsion of N. brasiliensis, or in Th2 or Treg cell numbers after allergen or IL-33 challenge, supporting our previous in vitro results (Figures 1F, S2D, and S2E; Halim et al., 2012b; Wong et al., 2012) . Additionally, using a separate model of ILC2 deletion in diphtheria toxin (DTx)-treated ICOS-T mice , we observed a similar defect in GATA3 + Treg and Th2 cell responses after IL-33 + 2W1S peptide administration . As reported previously, ILC3s may also be impaired by DTx in Icos fl-DTR-fl/+ Cd4 Cre/+ (ICOS-T) mice, although lung ILC3s are sparse and not substantially affected by IL-33-driven inflammation (Figures S2G and S2H) . Further, to investigate a potential role for B cells, we injected B cell-deficient Ighm À/À (mMT) mice with IL-33, followed by analysis for Th2 and Treg cells. We observed no significant difference in IL-33-driven Treg and Th2 cell expansion in the lungs of mMT compared to WT mice ( Figures S2I and S2J ). Moreover, immunofluorescence microscopy analysis of IL-33treated WT mice showed co-localization of Treg cells and ILC2s in the lungs ( Figure S2K ), as reported previously (Molofsky et al., 2015) . Thus, ILC2s are critical for allergen-and IL-33induced expansion of Th2 cells and GATA3 À and GATA3 + Treg cells.
OX40 Is Required for Expansion of Adaptive Type 2 Immunity by IL-33
We investigated possible cell-to-cell interactions that may influence IL-33-driven Th2 and Treg cell expansion and first focused on T cell co-receptors. Gene expression analysis for the tumor necrosis factor (TNF) receptor-superfamily was conducted using lung ILC2s and other IMMGEN immune cell datasets ( Figure 2A ). We observed high expression of Tnfrsf4 (OX40), an important T cell co-stimulatory receptor (Croft, 2010) , on Treg and activated CD4 + T cells. We confirmed that OX40 was expressed on lung GATA3 + and GATA3 À Treg cells in PBS, papain-, or IL-33-stimulated mice, but not Foxp3 À GATA3 À CD4 + T cells (Figures 2B, 2C, and S3A) . OX40 was also expressed on a smaller proportion of Th2 cells after IL-33 administration ( Figure 2B ). We hypothesized that OX40 may be important for mediating the IL-33driven expansion of Th2 and Treg cells. Using Tnfrsf4 À/À mice, we determined that the OX40 co-stimulatory molecule was essential for IL-33-mediated Treg cell expansion in the lungs ( Figures 2D-2F ). We observed similar requirements of OX40 for the development of lung Th2 cells in response to IL-33, while ILC2 expansion was unaffected ( Figure S3B ). Tnfrsf4 À/À mice also showed a similar defect in adaptive type 2 immunity after intranasal administration of papain ( Figures  2G-2I ). Thus, OX40 signaling is critical for the induction of IL-33-dependent adaptive type 2 immunity.
ILC2s Selectively Express OX40L in Response to IL-33 Next, we identified the critical OX40L-expressing cells by analyzing gene expression for Tnfsf4 and other TNF superfamily ligand transcripts. We found that Tnfsf4 (OX40L) gene expression was highest in naive lung ILC2s and substantially lower in any of the other tested immune cells ( Figure 3A ). To confirm these findings, we assessed OX40L expression on lung immune cells in mice stimulated intranasally with IL-25, IL-33, TSLP, papain, LPS, or PBS. While control mice did not show OX40L protein expression on any cells that we analyzed (ILC2s, B cells, CD4 + and CD8 + T cells, DCs, Macs, and NK cells), only ILC2s showed a significant induction of OX40L surface expression upon IL-33, papain, and to a lesser degree IL-25, stimulation ( Figures 3B, 3C , and S4A-S4C). Moreover, lung DCs from adult mice failed to induce OX40L expression in response to intranasal administration of any of these stimuli, including two separate TSLP formulations and anti-CD40 mAb treatment ( Figure S4D ). Also, OX40L + ILC2s significantly outnumbered OX40L + DCs after IL-33 administration and also exhibited higher intensity surface staining of OX40L (Figure S4E) . Notably, human ILC2s also strongly induced OX40L after IL-33 stimulation ( Figure S4F ). Additionally, IL-33 administration to mice by intranasal (i.n.) or intraperitoneal (i.p.) routes rapidly (day 2) increased Treg cell proliferation in the lung but not mediastinal lymph node (mLN), while ILC2s at both sites were activated and expressed ST2 ( Figures 3D and S4G ). When we measured the expression of OX40L on ILC2s after IL-33 administration, we observed that lung ILC2s expressed OX40L, while mLN ILC2s and ILC3s did not ( Figure 3E ). Lastly, proliferation of total CD4 + T cells was not significantly affected in either lung or mLN by IL-33 administration ( Figure S4H ). This led us to speculate that IL-33-driven local expansion of adaptive type 2 immune cells is governed by ILC2-restricted OX40L expression.
OX40L Expression by ILC2s Correlates with Tissue-Specific T Cell Proliferation
To further ascertain the importance of OX40L expression by ILC2s following IL-33-driven induction of adaptive type 2 immunity, we crossed Tnfsf4 fl/fl mice with Il7r Cre/+ mice. Although other immune cells such as ILC3s and CD4 + T cells also express IL7Ra, we did not observe OX40L expression in these populations. Efficient deletion of OX40L on ILC2s was achieved in Il7r Cre/+ Tnfsf4 fl/fl mice, as indicated by reduced expression of OX40L on lung ILC2s after IL-33 administration ( Figures 4A and S5A ). Next, we asked whether ILC2-targeted deletion of OX40L influenced the IL-33-driven effects on adaptive type 2 immunity. We administered IL-33 to Il7r Cre/+ , Il7r Cre/+ Rora fl/fl , and Il7r Cre/+ Tnfsf4 fl/fl mice on days 0 and 1, followed by analysis on day 5. Notably, Il7r Cre/+ Tnfsf4 fl/fl mice failed to induce Th2 cells and GATA3 + and GATA3 À Treg cell responses in the lungs after treatment ( Figures 4B-4D ). The observed defect produced a phenotype similar to naive control or IL-33-treated Il7r Cre/+ Rora fl/fl mice. We subsequently investigated lung, large intestine, and perigonadal adipose tissue for the IL-33/ILC2/OX40L-driven effect on adaptive type 2 immunity. Here we noted clearly divergent phenotypes with OX40L expression induced only on lung and adipose tissue-resident ILC2s but not in the intestine ( Figure 4E ). Nevertheless, ILC2 and ILC3 numbers in Il7r Cre/+ Tnfsf4 fl/fl mice were similar to those in control mice (Figures 4F, S5B , and S5D). Moreover, only these two sites exhibited IL-33-driven expansion of Th2 cells and GATA3 + and GATA3 À Treg cells (Figures 4G and S5C) . Importantly, ILC2-targeted deletion of OX40L phenocopied ILC2 deficiency. This indicated the critical nature of OX40L expression by ILC2s for establishing tissue-specific adaptive type 2 immunity.
OX40L on ILC2s Is Specifically Required for IL-33-Driven Effects on Adaptive Type 2 Immunity OX40L is reported on other IL7Ra + cell types, including CD4 + T cells and RORgt + ILC3s, and is widely described on CD11c + DCs Webb et al., 2016) . While we observed only OX40L on ILC2s after IL-33 stimulation, IL7Ra Cre -driven deletion of OX40L is not entirely ILC2 specific. To better control for possible OX40L signaling contributions from other immune cells, we intercrossed Tnfsf4 fl/fl mice with Itgax Cre , Rorc Cre/+ , and Cd4 Cre/+ mice to further exclude non-ILC2-driven effects. As before, we administered IL-33 to the indicated control or OX40L-targeted mice, followed by analysis for induction of adaptive type 2 immunity. While ILC2-deficient and ILC2-targeted OX40L-deficient Il7r Cre/+ Tnfsf4 fl/fl mice both failed to induce GATA3 + Treg, GATA3 À Treg, and Th2 cells, mice with DC-targeted (Itgax Cre Tnfsf4 fl/fl ), ILC3-targeted (Rorc Cre/+ Tnfsf4 fl/fl ), and CD4 + T cell-targeted (Cd4 Cre/+ Tnfsf4 fl/fl ) OX40L deletion showed no deficit compared to OX40L-sufficient control mice ( Figures 5A-5C ). Finally, we generated Il7r Cre/+ Rora fl/fl + Il7r Cre/+ Tnfsf4 fl/fl mixed bone marrow (BM) chimeric mice, in which ILC2s are OX40L deficient, to further investigate the role of OX40L on ILC2s ( Figure S6D ). The mixed BM chimeras (B and C) OX40 expression was analyzed on lung GATA3 + and GATA3 À Treg and Th2 cells on day 5 from WT mice treated with PBS, papain, or IL-33 (i.n., day 0 and 1). Fluorescence minus one (FMO) control was used to establish gating threshold. Percent OX40 + cells were calculated in the indicated populations and treatments and compared to Foxp3 À GATA3 À (DN) CD4 + T cells.
(D-F) Lung GATA3 + and GATA3 À Treg and Th2 cells were quantified from WT and Tnfrsf4 À/À mice on day 5 after IL-33 treatment (i.n., day 0 and 1).
(G-I) Lung GATA3 + and GATA3 À Treg and Th2 cells were quantified from WT and Tnfrsf4 À/À mice on day 5 after papain (Pap) treatment (i.n., day 0 and 1). showed a significant reduction, similar to ILC2-deficient BM chimeric mice, in GATA3 + and GATA3 À Treg cells after IL-33 administration compared to control mice ( Figures 5D and 5E) . Thus, OX40L expression on ILC2s is essential for IL-33-driven activation of adaptive type 2 immunity.
IL-33-ILC2-OX40L Pathway Is Critical for Allergen-Induced Adaptive Type 2 Immunity Protease allergens are potent inducers of IL-33 in the airways, which is a central mechanism by which they drive innate and adaptive type 2 immunity Hammad and Lambrecht, 2015) . In addition to Th2 cells, we investigated the role of IL-33 in mediating allergen-induced Treg cell responses in the lungs. Administration of the protease allergen papain led to an induction of lung GATA3 + and GATA3 À Treg cells on day 5 in WT mice (Figures 6A, 6B, and S7A ). Papain-induced Treg cell responses were significantly reduced in Il33 cit/cit (Il33 À/À ) or Il1rl1 À/À mice ( Figures 6A and 6B) , indicating the importance of IL-33 for mediating allergen-induced expansion of Treg cells in the airways. As expected, Th2 cells were also significantly reduced in Il33 cit/cit or Il1rl1 À/À mice compared to WT controls ( Figures 6C and 6D) . We then investigated the role of ILC2-expressed OX40L for driving adaptive type 2 immunity in the lungs after papain exposure. We observed a failure of Th2 cells and GATA3 + and GATA3 À Treg cells to develop in the lungs of Il7r Cre/+ Tnfsf4 fl/fl mice ( Figures 6A-6D ). Next we exposed Il7r Cre/+ , Il7r Cre/+ Rora fl/fl , and Il7r Cre/+ Tnfsf4 fl/fl mice to repeat exposures of papain after initial sensitization, followed by analysis of the lungs for multiple parameters of innate and adaptive type 2 inflammation ( Figure S7B ). On day 24 we found that Il7r Cre/+ Tnfsf4 fl/fl mice had significant reductions in Th2 cells and GATA3 + and GATA3 À Treg cells compared to Il7r Cre/+ controls ( Figures S7C-S7E) . These reductions were similar to those observed in ILC2-deficient mice. We also observed significant reductions in lung eosinophilia ( Figure 6E ) and M2 polarization by lung macrophages as assessed by intracellular staining for RELMa ( Figures 6F and 6G ; Nair et al., 2009) . We further investigated whether OX40L expression by ILC2s may influence adaptive type 2 immunity to another allergen. Administration of Alternaria alternata extract promoted an increase in lung Th2 cells, but also GATA3 + and -Treg cells by day 9, that was impaired in Il7r Cre/+ Tnfsf4 fl/fl mice ( Figure 6H ). Moreover, we found that the A. alternata induced increase in serum IgE was reduced in Il7r Cre/+ Tnfsf4 fl/fl mice ( Figure 6I ). Interestingly, CD11c Cre targeted OX40L deletion also resulted in reduced Th2 and Treg cells after A. alternate-induced airway inflammation ( Figure S7F) , suggesting that both DC-and ILC2-derived OX40L contribute to the response. Thus, ILC2-expressed OX40L is critical for mediating ILC2-induced innate and adaptive type 2 inflammation to allergen exposure in an IL-33-dependent pathway.
OX40L-Expressing ILC2s Are Essential for Adaptive Type 2 Immunity to Helminth Challenge To interrogate the importance of the ILC2-OX40L axis in complex immune challenges, we used the prototypical type 2 immunity-inducing parasitic helminth, N. brasiliensis, which traffics through the lung after infection, inducing profound and prolonged type 2 inflammation (Mohrs et al., 2001) . Besides Th2 cells, Treg cells are known to play an important role for wound healing and tissue remodeling of the lung (Chen et al., 2012; Taylor et al., 2012) . First, we characterized the adaptive type 2 immune response in the lungs of mice on day 28 after N. brasiliensis infection and observed substantial increases in GATA3 + and GATA3 À Treg cells and Th2 cells in control mice ( Figures 7A-7C and S7G) . By contrast, Il7r Cre/+ Tnfsf4 fl/fl mice exhibited a failure of the lung Th2 cells and GATA3 + and GATA3 À Treg cells to expand, with numbers remaining similar to uninfected control mice. Notably, this impairment mirrored that measured in Il7r Cre/+ Rora fl/fl mice ( Figures 7A-7C) . Lung histology demonstrated that Il7r Cre/+ Tnfsf4 fl/fl mice had reduced histological features of inflammation compared to infected control mice ( Figure 7D ), again similar to those in Il7r Cre/+ Rora fl/fl mice. While infected control mice mounted a prolific eosinophil response, we observed an impairment in Il7r Cre/+ Tnfsf4 fl/fl mice to induce eosinophilia in the lung ( Figure 7E ) or BAL ( Figure 7F ). Similar impairments were observed when we quantified RELMa + M2 polarized lung macrophages ( Figure 7G ) and BAL concentrations of IL-4 and IL-5 ( Figure 7H ), while IL-13 + Th2 cells were also significantly reduced in the lungs of Il7r Cre/+ Tnfsf4 fl/fl compared to control mice ( Figure 7I ). Moreover, by day 28 after infection, we observed a reduction of adaptive type 2 CD4 + T cells in the mLN, and total lung IgE concentration of both infected Il7r Cre/+ Rora fl/fl and Il7r Cre/+ Tnfsf4 fl/fl mice compared to controls ( Figures 7J-7M ). Furthermore, at 5 days after N. brasiliensis infection, we observed a modest increase in worm numbers of Il7r Cre/+ Tnfsf4 fl/fl mice compared to control mice ( Figure 7N ). Of note, while absolute cell numbers were reduced, we observed no reduction in Th2 cell frequency in infected Il7r Cre/+ Rora fl/fl or Il7r Cre/+ Tnfsf4 fl/fl mice compared to control mice. Moreover, no significant differences were observed in type 1 immunity (IFN-g production), NK cells, and CD8 + T cells of both Il7r Cre/+ Rora fl/fl and Il7r Cre/+ Tnfsf4 fl/fl mice compared to controls after infection ( Figures S7H-S7K ). Thus, these results indicate that the IL-33/ILC2/OX40L axis is broadly important for orchestrating innate and adaptive type 2 immunity following helminth challenge. 
DISCUSSION
The potential role of ILC2s as key potentiators of immune activation, performing as intermediaries between the damaged epithelium and the adaptive immune system, is currently an important and unresolved question. While previous studies have started to reveal mechanisms by which ILC2s can influence Th2 cell priming (Halim et al., , 2016 Mirchandani et al., 2014; Oliphant et al., 2014) , the continued importance of ILC2s in the presence of adaptive type 2 immunity is unclear (Van Dyken et al., 2016; Vé ly et al., 2016) , especially because Th2 and Treg cells may also be directly activated by IL-33 (Guo et al., 2015; Schiering et al., 2014) . Our results using ILC2-deficient mouse models indicated that IL-33-driven expansion of Th2 and Treg cells was dependent on ILC2s. As RORa is also expressed by T cells, it has been suggested that deletion of Rora in lymphocytes may directly alter T cell responses. Significantly, using Cd4 Cre/+ Rora fl/fl mice, we excluded the possibility that Rora deletion results in CD4 + T cell-intrinsic effects that diminish adaptive immunity. Indeed, we demonstrated that mice whose T cells lack RORa mounted equivalent type 2 adaptive immune responses to parasitic worm infection, papain allergen, and IL-33 as RORa-sufficient T cell controls.
To further elucidate the mechanism by which ILC2s can orchestrate Th2 and Treg cell responses, we identified costimulatory molecules that were counter-expressed on ILC2s and T cells. Gene expression data highlighted the potential importance of OX40/OX40L interactions, which have been linked pre-viously with the development of Th2 cell responses (Croft, 2010; Webb et al., 2016) . OX40 is expressed on memory T cells after TCR-mediated recall responses (Croft, 2010) and is also associated with Treg cell homeostasis and function . Additionally, we discovered that OX40L, which has been reported on other immune cells in response to type 2 alarmins (Croft, 2010; Webb et al., 2016) , was increased on lung ILC2s in response to IL-33.
Notably, we were unable to detect OX40L on lung-resident dendritic cells, or other lung cell populations, even after treating mice with TSLP. Although OX40L mRNA expression is reported in many models of type 2 inflammation, and OX40L protein expression can be induced on in vitro cell-cultured mouse and human DCs stimulated with various cytokines (e.g., TSLP) and antigens, the cellular expression of OX40L protein in vivo remains relatively opaque. Nevertheless, while alarmin stimulation did not induce OX40L expression on lung-resident DCs, our study with A. alternata-induced lung inflammation clearly showed a role for OX40L expression by CD11c + cells, confirming previous findings of impaired Th2 cell priming of OX40L-deficient DCs . As we did not observe OX40L on ILC2s in the draining mLNs, it appears that separate functions of OX40L are enforced by distinct cell types.
Moreover, while IL-33-mediated expansion of Th2 and Treg cells may involve an antigen-independent mechanism solely reliant on ILC2s, more complex antigens such as A. alternata and house dust mite activate multiple cellular targets, including DCs (de Kleer et al., 2016) . Similarly, neonatal mouse DCs in the lung transiently express OX40L, suggesting differential (A-C) Lung GATA3 + and GATA3 À Treg cells and Th2 cells were quantified on day 5 in the specified genotypes, treated with PBS or IL-33 (i.n., days 0 and 1). (D and E) Bone marrow and mixed-bone marrow chimeric mice were created with the indicated genotypes. 6 to 7 months after bone marrow transfer, mice received IL-33 (i.n., days 0 and 1) followed by quantification of lung GATA3 + Treg (D) and GATA3 À Treg (E) cells on day 5. Bar graphs indicate mean (±SEM). ANOVA, two repeat experiments. ns = not significant, *p % 0.05, **p % 0.01, ***p % 0.001, ***p % 0.0001. See also Figure S6 . expression patterns dependent on developmental stage (de Kleer et al., 2016) . Thus, ILC2-and DC-expressed OX40L may play partially compensatory roles and further study is required to resolve the complexity of how differing temporal expression, tissue environment, and the nature of the antigen encountered may influence the induction of these pathways in protecting the host.
We observed that OX40-deficient mice and mice with a conditional deletion of OX40L (Il7r Cre/+ Tnfsf4 fl/fl ) had significantly impaired Th2 and Treg cell responses following IL-33 administration, a phenotype similar to ILC2-deficient mice. Furthermore, mixed BM chimeric mice, in which only ILC2s were OX40L deficient, also failed to induce Treg cells following IL-33 administration. By contrast, conditional deletion of OX40L from T cells, dendritic cells, and ILC3s resulted in normal IL-33induced responses. The deletion of OX40L from ILC2s also curtailed the onset of type 2 immunity in the lungs of mice administered papain allergen or infected with parasitic helminths. Thus, OX40L expression on ILC2s, but not DCs, is essential for the robust onset of IL-33-induced type 2-mediated lung inflammation.
Previous studies have demonstrated that OX40-and OX40Ldeficient mice fail to develop type 2 responses characteristic of allergic lung inflammation (Hoshino et al., 2003; Jember et al., 2001) and showed that OX40L-deficient (Tnfsf4 À/À ) mice were less efficient at responding to Heligmosomoides polygyrus (Ekkens et al., 2003) . We now establish ILC2s, through their tissue-specific expression of OX40L in response to IL-33, as critical players in the local expansion of OX40-expressing Th2 and Treg cells and the initiation and maintenance of robust type 2 responses in the lung. The co-induction of Th2 and Treg cells via the same signaling pathways may serve to limit allergic inflammation, as indicated by the suppressive role of Treg cells on Th2 cell-driven lung inflammation (Suto et al., 2001) , while also promoting wound healing such as in response to helminthinduced damage (Pulendran and Artis, 2012) . Indeed, we showed that N. brasiliensis-induced adaptive type 2 immunity, important for lung damage repair (Chen et al., 2012) , is dependent on OX40L expression on ILC2s. Accordingly, we observed a profound reduction in eosinophils, alternatively activated Macs, and type 2 effector cytokines. Importantly, ILC2s and Treg and Th2 cells were detectable in normal numbers at baseline in Il7r Cre/+ Tnfsf4 fl/fl mice, and type 1 immunity was unaffected after immune challenge.
OX40L can be regulated in an age-and tissue-specific manner and can be induced on a range of immune cells under various inflammatory conditions (Croft, 2010; de Kleer et al., 2016; Webb et al., 2016) . The availability of a conditional OX40L allele will be of significant importance in continuing to identify critical cellular sources of OX40L in mouse models. For example, whether OX40L on ILC2s, in addition to DCs, is also instructive during neonatal establishment of persistent Th2 and Treg cells in response to IL-33 is unknown but of critical importance (de Kleer et al., 2016; Gollwitzer et al., 2014; Saluzzo et al., 2017; Steer et al., 2017) . In adult mice, however, we implicated OX40L expression on ILC2s in diverse lung pathologies. Other cellular signaling molecules such as ICOSL and PD-1L may also influence cross-talk between ILC2s and T cells, although the magnitude of the ILC2-specific effect and broad expression of these ligands on other immune cells suggests a different role compared to OX40L (Molofsky et al., 2015; Schwartz et al., 2017) . The tissue-specific OX40L expression profile of ILC2s was an intriguing finding that warrants further investigation. Environmental cues or developmental programs may influence the response and/or sensitivity of ILC2s to IL-33. Intestinal ILC2s express ST2 but are known to be more sensitive to IL-25 than lung ILC2s. Nevertheless, mLN ILC2s were activated by IL-33 but do not express OX40L. Whether ILC2s are directly involved in regulating follicular T and B cell responses is an intriguing question, given our observation of reduced IgE concentrations in Il7r Cre/+ Tnfsf4 fl/fl mice after allergen or helminth exposure, and the known function of OX40 in humoral immunity Gaspal et al., 2005; Jember et al., 2001; Tahiliani et al., 2017) . Significantly, delineating the effect of OX40L expression by ILC2s and other immune cells in specific anatomical locations will aid the refinement of proposed immunotherapies targeting the OX40L/OX40 interaction (Gauvreau et al., 2014; Linch et al., 2015) .
While important for establishing adaptive type 2 inflammation in the airways, we have not resolved the functional significance of the parallel ILC2-driven expansion of Treg cells. While Treg cells can suppress type 2 inflammation (Lewkowich et al., 2005; Morita et al., 2015; Suto et al., 2001) , a more synergistic role is observed in cases of type 1 immune suppression, wound healing, and metabolism. This synergy, in addition to similarities in development, led to the hypothesis that Treg cell function can intersect with that of Th2 cells (Chapoval et al., 2010; Panduro et al., 2016) . We indeed observed a substantial overlap in gene expression profiles between Th2 cells and Treg cells, but also ILC2s. Many of these genes such as Irf4, Gata3, Nrp1, Areg, and Il1rl1 have shared functions between these lineages (Arpaia et al., 2015; Monticelli et al., 2011; Odegaard and Chawla, 2015; Siede et al., 2016; Vasanthakumar et al., 2015) . Moreover, lung GATA3 + Treg cells were strongly induced by protease allergens and IL-33, and our data support previous findings that assign enhanced effector function to this subset (Wohlfert et al., 2011) . Further studies are required to dissect the IL-33-ILC2-OX40L axis on specific Treg cell subsets in homeostasis and disease.
In conclusion, we have revealed a critical immune-regulator checkpoint for tissue-specific orchestration of adaptive type 2 immunity, whereby the potent effect of the alarmin IL-33 on adaptive immunity is contingent on its upregulation of OX40L by ILC2s.
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Detailed methods are provided in the online version of this paper and include the following: Additional details for main figures Figure 1 : (A-C, 3 repeat experiments, mean % gated population in A), (D, single experiment), (E, n = 4,4,4,4 left to right, ANOVA, 3 repeat experiments), (F, n = 5,5,5 left to right, ANOVA, 2 repeat experiments), (G, n = 4,4,4,4 left to right, ANOVA, 3 repeat experiments) Figure 2 : (A, 2 independent datasets per group), (B-C, n = 5,5,5,5 left to right in C, ANOVA, 2 repeat experiments), (D-F, n = 10,9,10 left to right in D, n = 10,10,10 in E and F, ANOVA, 2 pooled repeat experiments), (G-I, n = 5,5,5 left to right, ANOVA, 2 repeat experiments) Figure 3 : (A, 2 independent datasets per group), (B, n = 3, mean percent gated shown ± S.D., 3 repeat experiments), (C, n = 3,3,3,3,3,3 left to right, ANOVA, 2 repeat experiments), (D, n = 4,4,4 left to right, ANOVA, 2 repeat experiments), (E, n = 4, percent gated shown ± SD two-tailed Student's t test, 2 repeat experiments) Figure 4 : (A, n = 4,4,4 left to right, percent gated shown ± S.D., 3 repeat experiments), (B-D, n = 4,8,8,8 left to right for B and C n = 4,4,4,4 left to right for D, ANOVA, 2 repeat experiments), (E-G, n = 5,5, percent gated shown ± SD for E, n = 8, 8,8,8 for F and G (n = 8,8,8,7 for Adipose), ANOVA, 2 pooled repeat experiments) Figure 5 : (A, n = 10,10,10 left to right, ANOVA, 2 pooled repeat experiments), (B, n = 10,10,10 left to right, ANOVA, 2 pooled repeat experiments), (C, n = 5,5,5 left to right, ANOVA, 2 repeat experiments), (D and E, n = 10,10,10 left to right, ANOVA, 2 pooled repeat experiments) Figure 6 : (A-D, n = 5,5,5,3,5 left to right, ANOVA, 2 repeat experiments), (E, n = 11,9,10 left to right, ANOVA, 3 repeat experiments (2 pooled experiments shown)), (F-G, n = 5,4,5 left to right, ANOVA, 2 repeat experiments, representative gate shown in F), (H-I, n = 5,5,5 left to right, ANOVA, 2 repeat experiments) Figure 7 : (A-C, n = 10,10,10,10 left to right, ANOVA, 3 repeat experiments (2 pooled experiments shown)), (D, 2 repeat experiments), (E-I, n = 5,5,5,5 left to right, ANOVA, 2 repeat experiments), (J-L, n = 10,10,10,10 left to right, ANOVA, 3 repeat experiments (2 pooled experiments shown)), (M, n = 5,5,5,5 left to right, ANOVA, 2 repeat experiments), (N, n = 10,13 left to right, two-tailed Student's t test, 2 pooled experiments)
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